Clinical Trial Update: Temozolomide and Radiation Therapy in Treating Patients With Gliomas [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the combination of temozolomide and radiation therapy for gliomas has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma

Drugs mentioned

• Temodar (Temozolomide)

Snippet

Sponsor: Radiation Therapy Oncology Group | Conditions: Brain and Central Nervous System Tumors | Phase 2 | Status: COMPLETED | Results posted: 2017-11-06